We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current INBP market cap is 9.86M. The company's latest EPS is USD 0.0037 and P/E is 89.19.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 52.77M | 63.56M | 56.25M | 50.67M | 50.32M |
| Operating Income | 3.26M | 5.78M | 2.75M | 120k | 251k |
| Net Income | 4.11M | 8.01M | 3.84M | -34k | 112k |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 22.94M | 25.44M | 25.25M | 25.43M | 26.21M |
| Total Liabilities | 16.88M | 11.11M | 6.68M | 6.57M | 6.97M |
| Total Equity | 6.07M | 14.33M | 18.58M | 18.86M | 19.24M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.34M | 3.05M | 4.09M | 1.23M | 943k |
| Investing | -110k | -199k | -465k | -111k | -553k |
| Financing | -1.3M | -3.04M | -3.51M | -136k | -29k |
| Market Cap | 9.86M |
| Price to Earnings Ratio | 89.19 |
| Price to Sales Ratio | 0.2 |
| Price to Cash Ratio | 5.97 |
| Price to Book Ratio | 0.52 |
| Dividend Yield | - |
| Shares Outstanding | 30.3M |
| Average Volume (1 week) | 63.47k |
| Average Volume (1 Month) | 27.16k |
| 52 Week Change | 48.16% |
| 52 Week High | 0.42 |
| 52 Week Low | 0.16375 |
| Spread (Intraday) | 0.06 (17.27%) |
| Company Name | Integrated BioPharma Inc (QX) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ir.ibiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
